Navigation Links
M/MK Series

ProductsM/MK Series
Company Tuttnauer Co. Ltd.
Item M/MK Series
Features Automatic shut off at the end of both the sterilization and dry cycles. A long life electro polished chamber and door. Double safety locking device prevents door from opening while chamber is pressurized. Overheat cutoff prevents burnout of heating elements in case of insufficient water in the chamber. Drain valve is located on the front, allowing for quick and easy draining of water reservoir. Dual safety thermostat to protect against overheating. International certifications.
Description Tuttnauer manual autoclaves set the standard for steam Sterilization. The Tuttnauer manual autoclave is designed to compliment any healthcare and laboratory facility. Our basic manual autoclave will satisfy all of your sterilization needs. Time tested reliability and durability are built into every Tuttnauer product. The Tuttnauer M Series is also available in a quick cycle model, the Kwiklave (MK). These sterilizers offer all the proven, dependable features of our manual autoclave, with the added benefit of reducing the total sterilization cycle time by 50%. Speed and reliability are accomplished without sacrificing load size.
Info Tuttnauer Co. Ltd.
Customer Service: (800) 624-5836
Web site: http://www.tuttnauer.com/

Related medicine products :

1. Series 20000 Legacy
2. Series 24 Watt Sealed CO2 OEM Lasers
3. EA/EKA Series
4. EHS Series
5. MLS-Series Top-Loading Autoclaves
6. Blood Coagulation Analyzer CG Series
7. Cytomics FC 500 Series
8. Series 400 Aggregometers
9. Series 500 Aggregometers
10. Series 490 Low Cost Automatic Optical Aggregometers
11. Series 590 Low Cost Whole Blood Aggregometers
... Immunosuppressant Control is a bilevel Cyclosporine control ... unique product is ideal for use with ... levels, such as C2 monitoring, which measures ... hours post-dose., ,Lyphochek Elevated Immunosuppressant Control can ...
Liquichek Hematology-16T Control is a hematology reference control used in monitoring determinations of blood cell values on TOA SYSMEX cell counters....
NEW Liquichek Reticulocyte Control (A)is an assayed whole blood control for evaluating the precision of automated methods of reticulocyte counting....
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays....
Medicine Products:
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Research Institute (WCRI) officially opened registration today for its 33rd Annual Issues ... Boston, MA . , The theme of the conference is “Persistent Challenges and ...
(Date:12/8/2016)... NJ (PRWEB) , ... December 08, 2016 , ... CURE ... cancer centers and advocacy groups, has aligned with Upstage Lung Cancer in efforts to ... making the announcement, Michael J. Hennessy, Jr said, “CURE Media Group is honored to ...
(Date:12/8/2016)... (PRWEB) , ... December 08, ... ... Presence Suite 10.2 version gives development continuity to its innovative Unified Instance ... channels management capacity. In addition, this new version optimizes the unattended auto-dialing ...
(Date:12/8/2016)... ... 08, 2016 , ... Today’s patients are encouraged to be ... SIGVARIS has created a new line of anti-embolism stockings to help prevent a ... benefits of graduated compression when transitioning from recovery to early rehabilitation. , The ...
(Date:12/8/2016)... ... 08, 2016 , ... The Dan Carlisle Agency, an Alabama-owned ... is announcing the launch of a charity drive to raise support and awareness ... and children in Birmingham has grown steadily since the 1980’s, and the Pathways ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Fla. , Dec. 9, 2016  Harmar Mobility, LLC announced ... and a member of the Board of Directors. Photo ... ... Mr. Dawson,s ... development of organizations across a variety of industries. He brings to ...
(Date:12/9/2016)... -- Research and Markets has announced the addition of ... offering. ... global travel vaccines market to grow at a CAGR of 6.83% ... scenario and the growth prospects of the global travel vaccines market ... revenue generated from the sales of various vaccines administered to actively ...
(Date:12/8/2016)... -- IRIDEX Corporation (NASDAQ: IRIX ) today announced ... stock, $0.01 par value (the "Offering" with such shares being ... terms of the Offering will depend on market and other ... no assurance as to whether or when the Offering may ... proceeds it will receive from this offering for working capital ...
Breaking Medicine Technology: